CTMX
CytomX Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CTMX fundamentals
CytomX Therapeutics (CTMX) released its earnings on Nov 6, 2025: revenue was 5.90M (YoY -82.35%), missed estimates; EPS was -0.09 (YoY -228.57%), missed estimates.
Revenue / YoY
5.90M
-82.35%
EPS / YoY
-0.09
-228.57%
Report date
Nov 6, 2025
CTMX Earnings Call Summary for Q3,2025
- Q3 2025 Financial & Clinical Updates:
- Key Takeaways:
- Positive Clinical Momentum:
- CX-2051 Phase I/II Updates:
- Investor Sentiment Drivers:
- Market-impacting Developments:
- Clinical Trial Progress & Regulatory Updates:
- Key Events:
- Investor Sentiment & Market Reaction:
- Potential Impact on Share Price:
- Q3 2025 Key Developments:
- Clinical Trial Progress:
- CX-2051 Enrollment & Safety Updates:
- **Loperamide Prophylaxis Reduces Diarrhea by 70%, Enabling Higher Dose Tolerability.
- Competitor Activity:
- **BioAtla's Bispecific Program Could Impact CytomX's Competitive Positioning.
- CX-2051 Enrollment & Safety Updates:
- Clinical Trial Progress:
- Q3 2025 Key Developments:
- Potential Impact on Share Price:
- Investor Sentiment & Market Reaction:
- Key Events:
- Clinical Trial Progress & Regulatory Updates:
- Market-impacting Developments:
- Investor Sentiment Drivers:
- CX-2051 Phase I/II Updates:
- Positive Clinical Momentum:
- Key Takeaways:
EPS
Revenue
Revenue & Expenses
CTMX has released its 2025 Q3 earnings report, with revenue of 5.96M, reflecting a YoY change of -82.16%, and net profit of -14.23M, showing a YoY change of -348.06%. The Sankey diagram below clearly presents CTMX's revenue sources and cost distribution.
Key Indicators
CytomX Therapeutics (CTMX) key financial stats and ratios, covering profitability, financial health, and leverage.
CytomX Therapeutics (CTMX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
CytomX Therapeutics (CTMX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
CytomX Therapeutics (CTMX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does CytomX Therapeutics (CTMX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track CytomX Therapeutics (CTMX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from CytomX Therapeutics’s earnings call?Did CytomX Therapeutics beat or miss consensus estimates last quarter?What is the market's earnings forecast for CytomX Therapeutics next quarter?What does CytomX Therapeutics do and what are its main business segments?What is CytomX Therapeutics's latest dividend and current dividend yield?What guidance did CytomX Therapeutics's management provide for the next earnings period?What factors drove the changes in CytomX Therapeutics's revenue and profit?What were the key takeaways from CytomX Therapeutics's earnings call?
